Novel Alpha Glucan GI Tolerability Study (Loris Chronic)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

October 11, 2021

Study Completion Date

October 31, 2021

Conditions

Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Drinkable solution

The volunteers will consume 300 ml of liquid solution containing the novel alpha glucan or glucose syrup

Trial Locations (1)

Clinical Innovation Lab, Lausanne

All Listed Sponsors

lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT05142137 - Novel Alpha Glucan GI Tolerability Study (Loris Chronic) | Biotech Hunter | Biotech Hunter